- N
Newton Investment Management Group
- Matthew Jenkin
Matthew Jenkin
Portfolio Mgr & Sr. Healthcare Research Anlayst at Newton Investment Management Group
Matthew Jenkin is an experienced finance professional specializing in healthcare equity investments. Currently serving as Portfolio Manager and Senior Healthcare Research Analyst at Newton Investment Management Group since February 2015, Matthew has previously held significant roles in reputable firms such as BlueCrest Capital Management, LLP, Balyasny Asset Management L.P., and Lehman/Barclays Capital Equity Strategies, focusing on healthcare alternative investments. Matthew began their career at Dreyfus as a healthcare portfolio manager and analyst, managing sizable healthcare investments. Academic achievements include a Bachelor of Science degree in Physiology and Molecular Biology from Tulane University and an MBA in Finance and Economics from New York University - Leonard N. Stern School of Business.
Org chart
Teams
Offices
This person is not in any offices
Newton Investment Management Group
‘Newton Investment Management Group’ describes a group of affiliated companies that provide investment advisory services under the brand name ‘Newton’ or ‘Newton Investment Management’. Those companies are Newton Investment Management Ltd in the UK, Newton Investment Management North America LLC in the US, and Newton Investment Management Japan Ltd. (“NIMJ”), and all are indirect subsidiaries of The Bank of New York Mellon Corporation (‘BNY Mellon’). We deliver outcomes for our clients across equity opportunities, income, absolute return (including fixed income), multi-asset solutions, thematic and sustainable strategies. Our capabilities are driven by our global investment research platform which harnesses a breadth of both fundamental and quantitative research. Assets under management: $100.6 billion (as at 30 September 2022) Offices: London, Boston, New York, San Francisco and Tokyo Newton provides discretionary and non-discretionary investment advice to institutional clients, including US and global pension funds, sovereign wealth funds, central banks, endowments, foundations, insurance companies, registered mutual funds, other pooled investment vehicles and other institutions, and, via BNY Mellon, to individuals. Important information: www.newtonim.com/terms
